Loading…
Predictive Factors for the Prognosis of Vogt-Koyanagi-Harada Disease
To identify the prognostic factors in Vogt-Koyanagi-Harada (VKH) disease. This study included 23 patients (46 eyes) with acute-phase VKHdivided into two subgroups: Group 1; acute-resolved (10 patients), group 2; chronic-recurrent (13 patients). Mean age were 29.5 ± 10.2 years in group 1, 35.8 ± 12.2...
Saved in:
Published in: | Ocular immunology and inflammation 2023-09, Vol.ahead-of-print (ahead-of-print), p.1-7 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | To identify the prognostic factors in Vogt-Koyanagi-Harada (VKH) disease.
This study included 23 patients (46 eyes) with acute-phase VKHdivided into two subgroups: Group 1; acute-resolved (10 patients), group 2; chronic-recurrent (13 patients).
Mean age were 29.5 ± 10.2 years in group 1, 35.8 ± 12.2 years group 2 (p = .033). Best-corrected visual acuity with logMAR at admission was 0.91 ± 0.65 in group 1, 0.88 ± 0.62 in group 2 (p = .798), and improved to 0.08 ± 0.24, 0.18 ± 0.6, respectively (p = .557). Extraocular findings were detected in 30% in group 1, and 53.8% in group 2 at the time of admission (p = .108). All patients were treated with 1 g/day 3-5 days intravenous steroid, and 10 patients had immunomodulatory treatment. Initiation of immunomodulatory therapy did not affect the prognosis (p = .676).
Older patients and/or who developed extraocular findings at the presentation were more prone to show recurrences. |
---|---|
ISSN: | 0927-3948 1744-5078 |
DOI: | 10.1080/09273948.2022.2159841 |